Lonza Group AG (LZAGY)
Healthcare · Biotechnology
2 members of Congress have disclosed 3 trades in Lonza Group AG (LZAGY) since 2023: 0 buys and 3 sales. The most recent was disclosed on Jan 7, 2024.
- Trades disclosed
- 3
- Members trading
- 2
- Buys / sells
- 0 / 3
- Reported value
- $17K–$80K
Keep following the company.
Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.
What else is happening at LZAGY
All research →Company filings and public records connected to this stock, ordered by when they became public or were first observed.
LZAGY: third_quarter 2026 lobbying report
Issues affecting healthcare manufacturing including supply chain, intellectual property, international trade, and tariffs.
Public: Oct 20, 2026, 3:36 PM EDTOriginal source ↗LZAGY: second_quarter 2026 lobbying report
Issues affecting healthcare manufacturing including supply chain, intellectual property, international trade, and tariffs.
Public: Jul 16, 2026, 8:26 PM EDTOriginal source ↗
Who traded LZAGY
- Rep. Josh Gottheimer (D-NJ-5)0 buys · 2 sales02Jan 7, 2024
- Rep. Daniel S. Goldman (D-NY-10)0 buys · 1 sale01Aug 13, 2023
All trades
- Jan 7, 2024$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded Dec 21, 2023 · disclosed Jan 7, 2024 · Joint
- Jan 7, 2024$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Sold (partial) Lonza Group AG LZAGY
$1K–$15K · Traded Dec 5, 2023 · disclosed Jan 7, 2024 · Joint
- Aug 13, 2023$15K–$50K
Rep. Daniel S. Goldman (D-NY-10)
$15K–$50K · Traded Jul 10, 2023 · disclosed Aug 13, 2023
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.